Literature DB >> 1914240

On making multiple comparisons in clinical and experimental pharmacology and physiology.

J Ludbrook.   

Abstract

1. It is a central thesis of this review that in clinical and experimental pharmacology and physiology the goal of statistical analysis should be to minimize the risk of making any false-positive inferences from the results of an experiment (experimentwise Type I error). 2. It is common in clinical and experimental pharmacology and physiology for the effects of several treatments to be tested within a single experiment. Specific intercomparisons of these several effects, made in a pairwise or more complex fashion, inflates the risk of making false-positive inferences unless special statistical procedures are used. 3. A number of multiple comparison procedures is described and their ability to control experimentwise Type I error is evaluated critically. 4. When only a few (less than 5) of all possible pairwise or more complex comparisons are made between treatment groups, the Dunn-Sidák procedure provides maximum protection against excessive experimentwise Type I error and is very convenient to use. 5. When a control group is compared with all other treatment groups in a pairwise fashion, especially when the number of groups is large, the Dunnett procedure is more powerful than the Dunn-Sidák. 6. If investigators insist on making all possible pairwise comparisons among treatment groups, the Tukey-Kramer procedure provides maximum protection against false-positive inferences but inflates the Type II error rate. If it is especially important to avoid Type II error then the more complicated, stepwise procedures of the Ryan-Peritz-Welsch variety should be considered.

Entities:  

Mesh:

Year:  1991        PMID: 1914240     DOI: 10.1111/j.1440-1681.1991.tb01468.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  34 in total

1.  Systemic and renal hemodynamic effects of the AT1 receptor antagonist, ZD 7155, and the AT2 receptor antagonist, PD 123319, in conscious lambs.

Authors:  Mona L Chappellaz; Francine G Smith
Journal:  Pflugers Arch       Date:  2006-10-19       Impact factor: 3.657

2.  Genioglossus reflex inhibition to upper-airway negative-pressure stimuli during wakefulness and sleep in healthy males.

Authors:  Danny J Eckert; R Doug McEvoy; Kate E George; Kieron J Thomson; Peter G Catcheside
Journal:  J Physiol       Date:  2007-03-29       Impact factor: 5.182

3.  The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility.

Authors:  Robert L Owens; Atul Malhotra; Danny J Eckert; David P White; Amy S Jordan
Journal:  J Appl Physiol (1985)       Date:  2009-11-25

4.  Effect of feed interval and feed type on splanchnic haemodynamics.

Authors:  A J Lane; R C Coombs; D H Evans; R J Levin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-07       Impact factor: 5.747

5.  Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.

Authors:  Scott A Irwin; Alana Iglewicz; Richard A Nelesen; Jessica Y Lo; Connie H Carr; Sheilani D Romero; Linda S Lloyd
Journal:  J Palliat Med       Date:  2013-06-27       Impact factor: 2.947

6.  Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.

Authors:  F Tomoda; R A Lew; A I Smith; A C Madden; R G Evans
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

7.  Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.

Authors:  R A Lew; F Tomoda; R G Evans; L Lakat; J H Boublik; L A Pipolo; A I Smith
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

8.  Scan tracking coordinates for improved centering of Stratus OCT scan pattern.

Authors:  Gianmarco Vizzeri; Christopher Bowd; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  J Glaucoma       Date:  2009-01       Impact factor: 2.503

9.  Mineralocorticoids, hypertension, and cardiac fibrosis.

Authors:  M Young; M Fullerton; R Dilley; J Funder
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

10.  A novel time series analysis approach for prediction of dialysis in critically ill patients using echo-state networks.

Authors:  T Verplancke; S Van Looy; K Steurbaut; D Benoit; F De Turck; G De Moor; J Decruyenaere
Journal:  BMC Med Inform Decis Mak       Date:  2010-01-21       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.